| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |